Apnimed, Inc.

Apnimed, Inc.

NNASDAQ:APMD
16.28
USD
-0.64
(-3.78%)
3.17EPS
Mar 03Next Earn

Important Dates

Apnimed, Inc.'s next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of June 30, 2026, Apnimed, Inc. has 39.82M shares outstanding.

Shares Outstanding39.82M

Financial Position

As of June 30, 2026, Apnimed, Inc. maintains a current ratio of 5.19, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities.

Current Ratio5.19
Quick Ratio4.88
Debt / Equity-45.61

Stock Price Statistics

USD

These figures are as of the close on November 16, 2026.

50-Day Moving Average20.29

Income Statement

USD

These figures cover the twelve months ended June 30, 2026.

Gross Profit10.87M
Pretax Income126.11M

Balance Sheet

USD

As of June 30, 2026, Apnimed, Inc. holds 172.80M in cash and equivalents against 80.35M in total debt, resulting in a net debt position of -93.21M. Total book value stands at -176.18M, with working capital of 149.19M providing operational flexibility.

Cash & Cash Equivalents172.80M
Total Debt80.35M
Net Debt-93.21M
Equity (Book Value)-176.18M
Book Value Per Share-4.42
Working Capital149.19M

Cash Flow

USD

These figures cover the twelve months ended June 30, 2026.

Free Cash Flow-18.11M
FCF Per Share-0.45

Margins

Over the twelve months ended June 30, 2026, Apnimed, Inc. posted a gross margin of 89.98, reflecting its pricing power and cost economics. The operating margin of -96.89 and net profit margin of 1,042.51 provide insight into operational efficiency.

Gross Margin89.98
Operating Margin-96.89
Pretax Margin1,043.98
Profit Margin1,042.51